ScholarIQanswers from OpenAlex

Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second‐line <scp>Helicobacter pylori</scp> eradication in Japan<scp>,</scp> and the influence of metronidazole resistance

PaperCitations, authors & open-access status

Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second‐line <scp>Helicobacter pylori</scp> eradication in Japan<scp>,</scp> and the influence of metronidazole resistance is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second‐line <scp>Helicobacter pylori</scp> eradication in Japan<scp>,</scp> and the influence of metronidazole resistance have?

ScholarIQcitation count

Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second‐line <scp>Helicobacter pylori</scp> eradication in Japan<scp>,</scp> and the influence of metronidazole resistance has 93 citations in the OpenAlex counts ScholarIQ stores.

When was Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second‐line <scp>Helicobacter pylori</scp> eradication in Japan<scp>,</scp> and the influence of metronidazole resistance published?

ScholarIQyear

Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second‐line <scp>Helicobacter pylori</scp> eradication in Japan<scp>,</scp> and the influence of metronidazole resistance has 2002 year in the ScholarIQ index.

What is the open-access status of Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second‐line <scp>Helicobacter pylori</scp> eradication in Japan<scp>,</scp> and the influence of metronidazole resistance?

ScholarIQoa status

Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second‐line <scp>Helicobacter pylori</scp> eradication in Japan<scp>,</scp> and the influence of metronidazole resistance has closed oa status in the ScholarIQ index.

What is the DOI of Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second‐line <scp>Helicobacter pylori</scp> eradication in Japan<scp>,</scp> and the influence of metronidazole resistance?

ScholarIQdoi

The DOI for Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second‐line <scp>Helicobacter pylori</scp> eradication in Japan<scp>,</scp> and the influence of metronidazole resistance is on the source record.

What is the PMID of Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second‐line <scp>Helicobacter pylori</scp> eradication in Japan<scp>,</scp> and the influence of metronidazole resistance?

ScholarIQpmid

The PMID for Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second‐line <scp>Helicobacter pylori</scp> eradication in Japan<scp>,</scp> and the influence of metronidazole resistance is on the source record.

What is the OpenAlex record for Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second‐line <scp>Helicobacter pylori</scp> eradication in Japan<scp>,</scp> and the influence of metronidazole resistance?

ScholarIQopenalex

The OpenAlex for Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second‐line <scp>Helicobacter pylori</scp> eradication in Japan<scp>,</scp> and the influence of metronidazole resistance is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial